Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-01-16

Clinical Trial Update: Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of Phase 1 and Phase 2 studies evaluating Selective Retina Therapy for clinically significant diabetic macular e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selective Retina Therapy (SRT)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED